Typicality: | 0.385 |
Saliency: | 0.315 |
in 2016 | 2 | temporal |
recently | 2 | temporal |
colleague → conduct → clinical trials | 5 |
colleague → conduct → clinical trial | 4 |
colleague → conduct → a phase 3 trial | 3 |
negative | neutral | positive |
0.077 | 0.834 | 0.089 |
Raw frequency | 12 |
Normalized frequency | 0.315 |
Modifier score | 0.500 |
Perplexity | 140.500 |